Passa al contenuto

Polyclonal antibodies (pAbs)

Production of Polyclonal Antibodies

Immunization of Animals

Animals (commonly rabbits, goats, sheep, or donkeys) are immunized with an antigen of interest, often mixed with an adjuvant to boost the immune response.

After multiple injections over several weeks, the animal’s immune system generates antibodies against various epitopes on the antigen.

Serum Collection

 Blood is collected and allowed to clot.

The serum (which contains antibodies) is separated and purified using techniques such as ammonium sulfate precipitation, protein A/G affinity chromatography, or ion-exchange chromatography.


Characteristics


Contain a diverse population of antibodies targeting multiple epitopes.

Typically composed of IgG, but may also include IgM, IgA, etc., depending on the species and immunization protocol.

Not renewable from the same batch once the animal is no longer available (unlike monoclonals.





Advantages of Polyclonal Antibodies

Multi-epitope binding:  Higher sensitivity; can bind to conformational and linear epitopes

Easier to produce:  Lower cost and faster to generate than monoclonals

Better in detecting variants:  Useful when target antigen is variable or partially denatured

Stronger signal:  Multiple antibodies enhance signal in assays

Limitations

Batch-to-batch variability:   Antibody profiles differ between production animals or over time

Cross-reactivity:  May bind off-target antigens due to lower specificity

Finite supply:  Once the source animal is no longer available, the exact antibody mix is lost

Unsuitable for therapeutic precision:  Lack the specificity required for many targeted clinical therapies

Accedi per lasciare un commento